
ArmInfo. Narek Karapetyan, a board member of the "Strong Armenia" party, has presented the third point of the program proposed by Samvel Karapetyan, leader of the political party, businessman, and philanthropist.
Narek Karapetyan recalled that the "five steps to a strong Armenia" economic concept presented by Samvel Karapetyan includes the creation of 300,000 jobs, especially in the regions, a 0% tax break for small businesses, a 20% reduction in drug prices, guaranteed purchase of harvested crops, and the construction of 20,000 affordable apartments for young and large families. In his video address, he focused on the component of the program related to a 20% reduction in drug prices. Narek Karapetyan emphasized that, according to research, one in five citizens is currently poor and has difficulty purchasing food. Meanwhile, middle-aged people face with a dilemma: whether to buy food or medications.
As Narek Karapetyan noted, if they come to power, the drug registration process will be simplified. Drugs registered in Europe will automatically be registered in Armenia. Given the strict requirements for pharmaceutical companies in the EU, there is high confidence that drugs registered in EU countries meet all quality requirements. As a result, the number of registered drugs in the country will reach 8,000-9,000, which, in turn, leading to lower prices.
Another pricing issue facing the country is the procurement of drugs from intermediaries rather than directly from manufacturers. Upon coming to power, it will be proposed to start purchasing directly from manufacturers, resulting in a significant reduction in the number of intermediaries and, consequently, a notable decrease in prices. Narek Karapetyan noted that because of the limited registration of medicine, people often purchase them abroad and smuggle them into the country illegally, or buy them at exorbitant prices on the black market, often stored in poor conditions and can result in even more serious health problems. Liberalizing the pharmaceutical market and expanding the list of registered medications will help resolve shortages, Narek Karapetyan said.